In the current study, we investigated whether tumour-intrinsic KEAP1/NRF2 mutations could be non-invasively imaged by [18F]FSPG PET imaging and whether aberrant system xc− expression could be exploited for treatment of refractive NSCLC tumours. Here, KEAP1 is linked to neoplasm.